Treatment Holiday mCRC — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Planned interruption of chemotherapy (oxaliplatin holiday or complete treatment break) during a period of disease control, with planned reinduction at biochemical or radiographic progression — to reduce cumulative toxicity while maintaining treatment efficacy
Treatment holidays in mCRC involve planned cessation of all or part of the chemotherapy regimen during disease control. Strategies include: (1) oxaliplatin stop-and-go (OPTIMOX1: stop oxaliplatin after 6 cycles, continue 5-FU/LV ± biologic), (2) complete chemotherapy-free interval (MRC COIN-B), (3) maintenance therapy de-escalation (fluoropyrimidine ± biologic). These approaches reduce cumulative toxicity (neuropathy, fatigue) without significantly compromising OS. Treatment is reinduced at progression (biochemical: rising CEA; or radiographic).
Reference: ESMO 2024 mCRC; OPTIMOX1; CAIRO3; MRC COIN-B